ALGN three-lens brief
Evidence-based stock research on ALGN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -2.15% yesterday. · Underperforming SPY by 10.1pp over 30 days.
- Moved -2.15% yesterday.
- Underperforming SPY by 10.1pp over 30 days.
- Analyst mean target $209.07 — 19% above current (14 analysts).
- Debt-to-equity of 2.0 — balance-sheet-heavy.
- Reported earnings on 2026-04-29.
ALGN closed at $175.06 (-2.15%) as of 2026-05-04. Market cap: $12.54B. P/E (trailing) 29.4. Positives: analyst mean target $209.07 — 19% above current (14 analysts).. Concerns: moved -2.15% yesterday.; underperforming SPY by 10.1pp over 30 days.. Last quarter: Revenue $1.04B, net income $112.77M, free cash flow $584.22M.
Why three lenses on ALGN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALGNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ALGN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALGN brief"></iframe>